All In Biotech

Drug Trial Radar · NCT06887959

A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries

A Phase 4, Open-label, Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine As Part of Multimodal Therapy for Acute Pain After Laparoscopic Procedures of the Intraperitoneal or Retroperitoneal Cavities or Arthroscopic Orthopedic Procedures

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

47

Actual

Start

Mar 27, 2025

Primary completion

Oct 27, 2025

Study completion Nov 10, 2025

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Mar 21, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effectiveness, safety, and tolerability of SUZ for acute pain after laparoscopic procedures of the intraperitoneal or retroperitoneal cavities or arthroscopic orthopedic procedures.

Conditions

  • Acute Pain

Interventions

  • SuzetrigineDrug

    Tablets for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Reporting Good, Very Good, or Excellent on a Patient Global Assessment (PGA) for Pain Control at the End of TreatmentTime frame: Day 14 or at Pain Resolution, whichever occurs first

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Scottsdale Clinical Trials

    Scottsdale, Arizona

  • Woodland International Research Group

    Little Rock, Arkansas

  • Gulfcoast Research Institute

    Sarasota, Florida

  • MedStar

    Baltimore, Maryland

  • Oasis Clinical Research

    Las Vegas, Nevada

  • Cooper University HealthCare (CUH)

    Camden, New Jersey

  • North Shore University Hospital - Anesthesiology

    Manhasset, New York

  • OrthoCarolina - Hip & Knee Center

    Charlotte, North Carolina

  • Eximia Research-Durham

    Durham, North Carolina

  • Duke University Hospital - Anesthesiology

    Durham, North Carolina

  • West Clinical Research

    Morehead City, North Carolina

  • Seaside Clinical Research Institute

    Wilmington, North Carolina

  • UH Cleveland Medical Center - Anesthesiology

    Cleveland, Ohio

  • University of Tennessee Medical Center - Anethesiology

    Knoxville, Tennessee

  • HD Research LLC | First Surgical Hospital

    Bellaire, Texas

  • Memorial Hermann Village

    Houston, Texas

  • Tidewater Clinical Research

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.